This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / RxSight Securities Fraud Lawsuit
Business securities lawsuit

RxSight Securities Fraud Lawsuit

Analysis based on 27 articles · First reported Jul 24, 2025 · Last updated Sep 06, 2025

Sentiment
-70
Attention
4
Articles
27
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is negatively impacted by the significant stock price declines of RxSight, which fell roughly 38% on two separate occasions after cutting its full-year revenue forecasts. This event highlights the risks associated with investing in companies that may not fully disclose 'adoption challenges' for their products, leading to investor losses and subsequent class-action lawsuits.

Medical Devices Legal Services
Event Summary

A securities class-action lawsuit has been filed against RxSight, Inc. and its senior executives by Bleichmar Fonti & Auld LLP. The lawsuit alleges violations of federal securities laws, claiming RxSight misled investors by touting strong sales of its Light Adjustable Lens (LAL) and Light Delivery Device (LDD) while failing to disclose 'adoption challenges' and a slowdown in LAL utilization that began in 2024. The truth was revealed when RxSight cut its 2025 full-year revenue forecast twice, first on April 3, 2025, and again on July 8, 2025, leading to two separate 38% drops in its stock price. The case is pending in the United States — United States District Court for the Northern District of California, and investors have until September 22, 2025, to seek appointment as lead plaintiff.

Entities Involved
stock
RxSight
RxSight is being sued for securities fraud due to alleged misleading statements about its Light Adjustable Lens (LAL) and Light Delivery Device (LDD) sales and undisclosed 'adoption challenges'. Its stock price declined significantly after cutting revenue forecasts.
Importance 100.0 Sentiment -80.0
per
Ross Shikowitz
Importance 0.0 Sentiment 0.0
priv
Bleichmar Fonti & Auld LLP
Importance 0.0 Sentiment 0.0
govactor
United States — United States District Court for the Northern District of California
Importance 0.0 Sentiment 0.0
Relationships
Ross Shikowitz partner ↔ Bleichmar Fonti & Auld LLP Ross Shikowitz is a partner at the law firm Bleichmar Fonti & Auld LLP, where he focuses on securities and corporate gov
Ross Shikowitz related ↔ United States — United States District Court for the Northern District of California
Bleichmar Fonti & Auld LLP related ↔ United States — United States District Court for the Northern District of California
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.